Profiles on Central Nervous System

Published within

« | 1 | 2 | 3 | 4 | 5 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Elan Corporation, plc

Elan Corporation, plc (Elan or 'the company') is a neuroscience-based biotechnology company focusing on the discovery, development, manufacture and marketing of therapies in neuroscience, autoimmune diseases, and severe chronic pain. The company demerged a substantial portion of Elan's drug discovery business into Prothena Corporation, an independent, publicly traded company, in December 2012. The company primarily operates in the US and Ireland. Elan is headquartered in Dublin, Ireland, and employed 245

Published By MarketLine
03 Sep 2013 $175
Buy
Company Profile
Company Profile

Acorda Therapeutics, Inc.

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. Acorda's marketed products include Ampyra/Fampyra (dalfampridine) and Zanaflex capsules and tablets (tizanidine hydrochloride). The company primarily operates in the US, where it is headquartered in Ardsley, New York, and employed 378

Published By MarketLine
20 Sep 2013 $175
Buy
Company Profile
Company Profile

H. Lundbeck A/S

H. Lundbeck A/S (Lundbeck or 'the company') is a specialty pharmaceutical company focusing in the field of psychiatric and neurological disorders. The company's majority of operations are in the Americas and Europe. It is headquartered in Valby, Denmark and employed 5,639 people as of December 31, 2012.

Published By MarketLine
25 Sep 2013 $175
Buy
Company Profile
Company Profile

Ipsen S.A.

Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group primarily operates in Europe and North America. It is headquartered in Boulogne-Billancourt, France, and employed 4,835 people as of December 31, 2012.

Published By MarketLine
09 Oct 2013 $175
Buy
Company Profile
Company Profile

Biogen Idec, Inc.

Biogen Idec (Biogen or 'the company') is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of oncology, neurology and immunology. The company's key products include Tysabri (natalizumab), Avonex (Interferon beta-1a), and Rituxan (rituximab). The company primarily operates in the US and Europe. It is headquartered in Weston, Massachusetts and employed about 5,950 people as of December 31, 2012

Published By MarketLine
28 Oct 2013 $175
Buy
Company Profile
Company Profile

Purdue Pharma L.P.

Purdue Pharma (Purdue or 'the company') is a privately-held pharmaceutical company engaged in the research, development, production and distribution of both prescription and over-the-counter medicines and hospital products. It primarily operates in the US where it is headquartered in Stamford, Connecticut. Purdue and its independent associated companies have their presence in more than 30 countries. The company employs more than 5,000 people worldwide.

Published By MarketLine
29 Oct 2013 $175
Buy
Company Profile
Company Profile

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle disorders. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 157 people as of December 31, 2012.

Published By MarketLine
29 Oct 2013 $175
Buy
Company Profile
Company Profile

Shire plc

Shire (or 'the company') is a global specialty biopharmaceutical company. The company operates in North America, Europe and other countries. It is headquartered in Dublin, Republic of Ireland, and employed 5,367 people as of December 31, 2012.

Published By MarketLine
27 Nov 2013 $175
Buy
Company Profile
Company Profile

Merck KGaA

Merck KGaA (or 'the group') is a leader in pharmaceutical, chemical and life science. The group offers branded prescription drugs, and chemicals for high-tech applications. The Merck family holds an approximately 70% interest in the group and shareholders own the remaining approximately 30%. The group operates in 66 countries across the world. It is headquartered in Darmstadt, Germany and employed 38,847 people as of December 31, 2012.

Published By MarketLine
05 Dec 2013 $175
Buy
Company Profile
Company Profile

Recordati S.p.A.

Recordati S.p.A. (Recordati or 'the company') is a mid-sized European pharmaceutical company marketing ethical pharmaceuticals, most of which have been in-licensed for development and marketing within specific European markets. The company markets its products in more than 100 countries, primarily in the EU. It is headquartered in Milan, Italy, and employed 3,369 people as of December 31, 2012.

Published By MarketLine
12 Dec 2013 $175
Buy

« | 1 | 2 | 3 | 4 | 5 | » »|

No help is available.